# Vir Biotechnology, Inc.: Form DEF 14A, filed Apr 19, 2024

- Company: [Vir Biotechnology, Inc.](/companies/vir.md) (CIK 1706431)
- Form: DEF 14A
- Filed: 2024-04-19
- Accepted by EDGAR: Apr 19, 2024, 08:32 ET
- Period: 2024-05-29
- Accession: 0001140361-24-020684
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1706431/000114036124020684/edge20022607x1_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1706431/000114036124020684/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1706431/000114036124020684/edge20022607x1_def14a.htm

Filed Apr 19, 2024.
Source: SEC EDGAR, the filing index for accession 0001140361-24-020684. Last ingested by Listed: Nov 6, 2026, 19:03 ET. No prices; not investment advice.